United States
Telesair is a Southern California based medical device company with a mission to provide hospital-level respiratory care in the home. Founded in 2020, the company is currently in stealth mode as it develops groundbreaking respiratory care solutions to facilitate early patient discharge from hospitals to their homes. Led by experts in respiratory technology and commercialization, Telesair aims to enhance the standard of care, ultimately leading to improved patient outcomes and a more efficient healthcare system.
Notably, the company recently secured a $22.00M Series A investment on 10 January 2023, attracting a diverse group of prominent investors including Zhencheng Capital, Berkeley Catalyst Fund, Medical Devices of Tomorrow, Pasaca Capital, ShangBay Capital, Ultrastar Ventures, and Honeywell. This significant investment signifies confidence in Telesair's innovative approach and its potential to revolutionize respiratory care within the Health Care industry.
Overall, Telesair appears to be a promising player in the evolving healthcare landscape, and its focus on advancing respiratory care solutions demonstrates potential for substantial impact on patient care and healthcare efficiency.
